Stay updated on Pyrotinib Combo in HR+/HER2- Clinical Trial
Sign up to get notified when there's something new on the Pyrotinib Combo in HR+/HER2- Clinical Trial page.

Latest updates to the Pyrotinib Combo in HR+/HER2- Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing v3.5.3, indicating a new site release. The change affects only the version label and does not modify the study details or displayed information.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedThe page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a general platform release rather than modifications to the clinical trial record content.SummaryDifference0.1%

- Check46 days agoChange DetectedAdded Revision: v3.5.2 to the record history and removed Revision: v3.5.0.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was deleted from the Study Record Versions.SummaryDifference0.1%

- Check82 days agoChange DetectedAdded a new history entry Revision: v3.4.3 and removed Revision: v3.4.2 from the Study Record history.SummaryDifference0.1%

- Check111 days agoChange DetectedAdded Revision: v3.4.2 to the record history. The previous government funding notice (Revision: v3.4.1) was removed.SummaryDifference0.9%

Stay in the know with updates to Pyrotinib Combo in HR+/HER2- Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pyrotinib Combo in HR+/HER2- Clinical Trial page.